Ischemia-reperfusion of rat livers decreases liver and increases kidney multidrug resistance-associated protein 2 (Mrp2)

Toxicological Sciences

Volumn 101, Issue 1, 2008, Pages 171-178

  Tanaka, Yuji ^a   Chen, Chuan ^a   Maher, Jonathan M ^a   Klaassen, Curtis D ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Cholestasis; Ischemia reperfusion; Mrps; Remote organ; Transplantation

Indexed keywords

ANION; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; IMMUNOFLUORESCENCE; INFLAMMATION; KIDNEY PARENCHYMA; LIVER; LIVER DYSFUNCTION; LIVER INJURY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DNA; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; LIVER DISEASES; MALE; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RNA, MESSENGER;

RATTUS;

EID: 36949012546     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfm261     Document Type: Article

References (46)

1. Alary, J., Bravais, F., Cravedi, J. P., Debrauwer, L., Rao, D., and Bories, G. (1995). Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in the rat. Chem. Res. Toxicol. 8, 34-39.
2. Assem, M., Schuetz, E. G., Leggas, M., Sun, D., Yasuda, K., Reid, G., Zelcer, N., Adachi, M., Strom, S., Evans, R. M., et al. (2004). Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J. Biol. Chem. 279, 22250-22257.
3. Belinsky, M. G., Dawson, P. A., Shchaveleva, I., Bain, L. J., Wang, R., Ling, V., Chen, Z. S., Grinberg, A., Westphal, H., Klein-Szanto, A., et al. (2005). Analysis of the in vivo functions of MrP3. Mol. Pharmacol. 68, 160-168.
4. Ben-Ari, Z., Pappo, O., and Mor, E. (2003). Intrahepatic cholestasis after liver transplantation. Liver Transpl. 9, 1005-1018.
5. Bodo, A., Bakos, E., Szeri, F., Varadi, A., and Sarkadi, B. (2003). The role of multidrug transporters in drug availability, metabolism and toxicity. Toxicol. Lett. 133, 140-141.
6. Braun, N., Dette, S., and Viebahn, R. (2003). Impairment of renal function following liver transplantation. Transplant. Proc. 35 1458-1460.
7. Buchler, M., Konig, J., Brom, M., Kartenbeck, J., Spring, H., Horie, T., and Keppler, D. (1996). cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J. Biol. Chem. 271, 15091-15098.
8. Chen, C., and Klaassen, C. D. (2004). Rat multidrug resistance protein 4 (Mrp4, Abcc4): Molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility. Biochem. Biophys. Res. Commun. 317, 46-53.
9. Chen, C., Slitt, A. L., Dieter, M. Z., Tanaka, Y., Scheffer, G. L., and Klaassen, C. D. (2005). Up-regulation of Mrp4 expression in kidney of Mrp2-deficient TR- rats. Biochem. Pharmacol. 70, 1088-1095.
10. Cherrington, N. J., Hartley, D. P., Li, N., Johnson, D. R., and Klaassen, C. D. (2002). Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane. receptor activators in rats. J. Pharmacol. Exp. Ther. 300, 97-104.
11. Cole, S. P., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almqaist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M., and Deeley, R. G. (1992). Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258 1650-1654.
12. Colletti, L. M., Remick, D. G., Burtch, G. D., Kunkel, S. L., Strieter, R. M., and Campbell, D. A., Jr, (1990). Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/ reperfusion injury in the rat. J. Clin. Invest. 85, 1936-1943.
13. Denk, G. U., Soroka, C. J., Takeyama, Y., Chen, W. S., Schuetz, J. D., and Boyer, J. L. (2004). Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J. Hepatol. 40, 585-591.
14. Denson, L. A., Auld, K. L., Schiek, D. S., McClure, M. H., Mangelsdorf, D. J., and Karpen, S. J. (2000). Interleukin-1 beta suppresses retinoid trans-activation of two hepatic transporter genes involved in bile formation. J. Biol. Chem. 275, 8835-8843.
15. Denson, L. A., Bohan, A., Held, M. A., and Boyer, J. L. (2002). Organ-specific alterations in RAR alpha:RXR alpha abundance regulate rat Mrp2 (Abcc2) expression in obstructive cholestasis. Gastroenterology 123, 599-607.
16. Elferink, M. G., Olinga, P., Draaisma, A. L., Merema, M. T., Faber, K. N., Slooff, M. J., Meijer, D. K., and Groothuis, G. M. (2004). LPS-induced downregulation of MRP2 and BSEP in human liver is due to a post-transcriptional process. Am. J. Physiol. Gastrointest Liver. Physiol. 287, G1008-G1016.
17. Hirohashi, T., Suzuki, H., Takikawa, H., and Sugiyama, Y. (2000). ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J. Biol. Chem. 275, 2905-2910.
18. Homolya, L., Varadi, A., and Sarkadi, B. (2003). Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate. Biofactors 17, 103-114.
19. Hossain, M. A., Wakabayashi, H., Izuishi, K., Okano, K., Yachida, S., and Maeta, H. (2006). The role of prostaglandins in liver ischemia-reperfusion injury. Curr. Pharm. Des. 12, 2935-2951.
20. Ji, B., Ito, K., and Horie, T. (2004a). Multidrug resistance-associated protein 2 (MRP2) enhances 4-hydroxynonenal-induced toxicity in Madin-Darby canine kidney II cells. Chem. Res. Toxicol. 17, 158-164.
21. Ji, B., Ito, K., Sekine, S., Tajima, A., and Horie, T. (2004b). Ethacrynic-acid-induced glutathione depletion and oxidative stress in normal and Mrp2-deficient rat liver. Free. Radic. Biol. Med. 37 1718-1729.
22. Ji, B., Ito, K., Suzuki, H., Sugiyama, Y., and Horie, T. (2002). Multidrug resistance-associated protein2 (MRP2) plays an important role in the biliary excretion of glutathione conjugates of 4-hydroxynonenal. Free. Radic. Biol. Med. 33, 370-378.
23. Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., and Edwards, P. A. (2002). Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. 277, 2908-2915.
24. Keppler, D., Leier, I., and Jedlitschky, G. (1997). Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol. Chem. 378, 787-791.
25. Kruh, G. D., and Belinsky, M. G. (2003). The MRP family of drug efflux pumps. Oncogene 22, 7537-7552.
26. Lee, J., Azzaroli, F., Wang, L., Soroka, C. J., Gigliozzi, A., Setchell, K. D., Kramer, W., and Boyer, J. L. (2001). Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 121, 1473-1484.
27. Lemasters, J. J., and Thurman, R. G. (1997). Reperfusion injury after liver preservation for transplantation. Annu. Rev. Pharmacol. Toxicol. 37, 327-338.
28. Loe, D. W., Almquist, K. C., Deeley, R. G., and Cole, S. P. (1996). Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. J. Biol. Chem. 271 9675-9682.
29. Maher, J. M., Dieter, M. Z., Aleksunes, L. M., Slitt, A. L., Guo, G. L., Dalton, T. P., Chan, J. Y., Scheffer, G. L., Tanaka, Y., Manautou, J. E., et al. (2007). Oxidative and electrophilic stress induces Mrp transporters via the Nrf2 transcriptional pathway. Hepatology 46, 1597-1610.
30. Nakamura, J., Nishida, T., Hayashi, K., Kawada, N., Ueshima, S., Sugiyama, Y., Ito, T., Sobue, K., and Matsuda, H. (1999). Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression. Biochem. Biophys. Res. Commun. 255, 143-149.
31. Paulusma, C. C., Bosma, P. J., Zaman, G. J., Bakker, C. T., Otter, M., Scheffer, G. L., Scheper, R. J., Borst, P., and Oude Elferink, R. P. (1996). Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271, 1126-1128.
32. Paulusma, C. C., Kool, M., Bosma, P. J., Scheffer, G. L., ter Borg, F., Scheper, R. J., Tytgat, G. N., Borst, P., Baas, F., and Oude Elferink, R. P. (1997). A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 25, 1539-1542.
33. Schaub, T. P., Kartenbeck, J., Konig, J., Vogel, O., Witzgall, R., Kriz, W., and Keppler, D. (1997). Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J. Am. Soc. Nephrol. 8, 1213-1221.
34. Silva, V. M., Thibodeau, M. S., Chen, C., and Manautou, J. E. (2005). Transport deficient (TR-) hyperbilirubinemic rats are resistant to acetaminophen hepatotoxicity. Biochem. Pharmacol. 70, 1832-1839.
35. Slitt, A. L., Cherrington, N. J., Maher, J. M., and Klaassen, C. D. (2003). Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites. Drug. Metab. Dispos. 31, 1176-1186.
36. Takamatsu, Y., Shimada, K., Chijiiwa, K., Kuroki, S., Yamaguchi, K., and Tanaka, M. (2004). Role of leukotrienes on hepatic ischemia/reperfusion injury in rats. J. Surg. Res. 119, 14-20.
37. Tanaka, Y., Chen, C., Maher, J. M., and Klaassen, C. D. (2006). Kupffer cell-mediated downregulation of hepatic transporter expression in rat hepatic ischemia-reperfusion. Transplantation 82, 258-266.
38. Tanaka, Y., Kobayashi, Y., Gabazza, E. C., Higuchi, K., Kamisako, T., Kuroda, M., Takeuchi, K., Iwasa, M., Kaito, M., and Adachi, Y. (2002). Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice. Am. J. Physiol. Gastrointest. Liver Physiol. 282, G656-G662.
39. Tanaka, Y., Maher, J. M., Chen, C., and Klaassen, C. D. (2007). Hepatic ischemia-reperfusion induces renal heme oxygenase-1 (HO-1) via nf-e2-related factor 2 (Nrf2) in rats anti mice. Mol. Pharmacol. 71, 817-825.
40. Teng, S., and Piquette-Miller, M. (2005). The involvement of the pregnane X receptor in hepatic: Gene regulation during inflammation in mice. J. Pharmacol. Exp. Ther. 312, 841-848.
41. Trauner, M., Arrese, M., Soroka, C. J., Ananthanarayanan, M., Koeppel, T. A., Schlosser, S. F., Suchy, F. J., Keppler, D., and Boyer, J. L. (1997). The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113, 255-264.
42. van Aubel, R. A., Smeets, P. H., Peters, J. G., Bindels, R. J., and Russel, F. G. (2002). The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: Putative efflux pump for urinary cAMP and cGMP. J. Am. Soc. Nephrol. 13, 595-603.
43. Vollrath, V., Wielandt, A. M., Iruretagoyena, M., and Chianale, J. (2006). Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene. Biochem. J. 395, 599-609.
44. Wanner, G. A., Ertel, W., Müller, P., Höfer, Y., Leiderer, R., Menger, M. D., and Messmer, K. (1996). Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 5, 34-40.
45. Wielinga, P. R., Reid, G., Challa, E. E., van der Heijden, I., van Deemter, L., de Haas, M., Mol, C., Kuil, A. J., Groeneveld, E., Schuetz, J. D., et al. (2002). Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol. Pharmacol. 62, 1321-1331.
46. Zeng, H., Bain, L. J., Belinsky, M. G., and Kruh, G. D. (1999). Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. Cancer Res. 59, 5964-5967.